Ready to partner (original) (raw)

Nature Structural & Molecular Biology volume 10, pages 158–159 (2003)Cite this article

The structure of the extracellular domain of HER2/ErbB2 reveals why the receptor is an orphan and provides valuable insight into the receptor's readiness to partner with other ErbB family members.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Figure 1: ErbB2/HER2 association.

References

  1. Cohen, S. & Carpenter, G. Proc. Natl. Acad. Sci. USA 72, 1317–1321 (1975).
    Article CAS PubMed PubMed Central Google Scholar
  2. Slamon, D.J. et al. Science 235, 177–182 (1987).
    Article CAS PubMed Google Scholar
  3. Slamon, D.J. et al. N. Engl. J. Med. 344, 783–792 (2001).
    Article CAS PubMed Google Scholar
  4. Carter, P., Fendly, B.M., Lewis, G.D. & Sliwkowski, M.X. Breast Disease 11, 103–111 (2000).
    Article CAS PubMed Google Scholar
  5. Cho, H.S. & Leahy, D.J. Science 297, 1330–1333 (2002).
    Article CAS PubMed Google Scholar
  6. Cho, H.S. et al. Nature 421, 756–760 (2003).
    Article CAS PubMed Google Scholar
  7. Yarden, Y. & Sliwkowski, M.X. Nat. Rev. Mol. Cell Biol. 2, 127–137 (2001).
    Article CAS PubMed Google Scholar
  8. Ogiso, H. et al. Cell 110, 775–787 (2002).
    Article CAS PubMed Google Scholar
  9. Garrett, T.P. et al. Cell 110, 763–773 (2002).
    Article CAS PubMed Google Scholar
  10. Agus, D.B. et al. Cancer Cell 2, 127–137 (2002).
    Article CAS PubMed Google Scholar
  11. Molina, M.A. et al. Cancer Res. 61, 4744–4749 (2001).
    CAS PubMed Google Scholar
  12. Siegel, P.M. & Muller, W.J. Proc. Natl. Acad. Sci. USA 93, 8878–8883 (1996).
    Article CAS PubMed PubMed Central Google Scholar
  13. Brennan, P.J., Kumogai, T., Berezov, A., Murali, R. & Greene, M.I. Oncogene 19, 6093–6101 (2000).
    Article CAS PubMed Google Scholar
  14. Horan, T. et al. J. Biol. Chem. 270, 24604–24608 (1995).
    Article CAS PubMed Google Scholar
  15. Ferguson, K.M., Darling, P.J., Mohan, M.J., Macatee, T.L. & Lemmon, M.A. EMBO J. 19, 4632–4643 (2000).
    Article CAS PubMed PubMed Central Google Scholar
  16. Padhy, L.C., Shih, C., Cowing, D., Finkelstein, R. & Weinberg, R.A. Cell 28, 865–871 (1982).
    Article CAS PubMed Google Scholar
  17. Schechter, A.L. et al. Nature 312, 513–516 (1984).
    Article CAS PubMed Google Scholar
  18. Segatto, O., King, C.R., Pierce, J.H., Di Fiore, P.P. & Aaronson, S.A. Mol. Cell. Biol. 8, 5570–5574 (1988).
    Article CAS PubMed PubMed Central Google Scholar
  19. Adelsman, M.A., Huntley, B.K. & Maihle, N.J. J. Virol. 70, 2533–2544 (1996).
    CAS PubMed PubMed Central Google Scholar

Download references

Author information

Authors and Affiliations

  1. a stockholder and full-time employee of Genentech, Inc. Genentech, Inc. manufactures and sells Herceptin®,
    Mark X. Sliwkowski

Authors

  1. Mark X. Sliwkowski
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Sliwkowski, M. Ready to partner.Nat Struct Mol Biol 10, 158–159 (2003). https://doi.org/10.1038/nsb0303-158

Download citation

This article is cited by